- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Gilead Sciences Inc. (GILD)
Index:
- Change Today: $0.00
- 52 Week High: $87.29
- 52 Week Low: $63.15
- Currency: US Dollars
- Shares Issued: 1,246.00m
- Volume: 46,388
- Market Cap: $88,055m
- RiskGrade: 120
Latest ShareCast News
GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill
By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Gilead raises 2020 forecasts after Covid-19 surge boosts remdesivir
By Abigail Townsend
Date: Monday 11 Jan 2021
(Sharecast News) - Gilead Sciences has upped its full-year profit guidance following strong sales of its Covid-19 treatment remdesivir.
FDA grants EUA for Eli Lilly treatment in conjunction with Remdesivir
By Alexander Bueso
Date: Friday 20 Nov 2020
(Sharecast News) - The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead Sciences's remdesivir.
GILD Market Data
| Currency | US Dollars |
| Share Price | $ 70.67 |
| Change Today | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $87.29 |
| 52 Week Low | $63.15 |
| Volume | 46,388 |
| Shares Issued | 1,246.00m |
| Market Cap | $88,055m |
| RiskGrade | 120 |
What The Brokers Say
| Strong Buy | 4 |
| Buy | 8 |
| Neutral | 17 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 30 |
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
You are here: research
Digital Look Ltd,
10 Lower Thames St,
London EC3R 6EN
10 Lower Thames St,
London EC3R 6EN